Sightsavers Logo
Research centre
  • Home
  • About us
  • Research approach
  • Research studies and publications
  • Evidence gap maps
Join in:
  • Join in: Facebook
  • Join in: Twitter
  • Join in: Instagram
  • Join in: LinkedIn
  • Join in: YouTube
  • Global
  • Close search bar
    Donate
    • Home
    • About us
    • Research approach
    • Research studies and publications
    • Evidence gap maps
    Publication

    Resuming NTD activities in the context of COVID-19: an investigation into the advantages of risk assessment processes to mitigate the transmission of COVID-19 during NTD delivery

    Journal: International Health

    Summary

    The neglected tropical disease (NTD) sector is adapting to the uncertain circumstances of COVID-19. The development of the Risk Assessment and Mitigation Action (RAMA) tool was driven by partners of the Ascend programme to enable countries to restart NTD activities following the World Health Organization advisories in April and July 2020.

    This article explores the advantages of the RAMA process for NTD delivery.

    This article is part of a special supplement in International Health focusing on the Ascend neglected tropical disease programme in West and Central Africa. You can access the other articles in the supplement on the International Health website.

    Read the journal article

    Related tags

    Neglected tropical diseases (NTDs general)
    Publication details
    Date published
    21 September 2022
    Type
    Original research
    Journal
    International Health
    Themes/conditions
    Neglected tropical diseases (NTDs general)
    Publication details
    Date published
    21 September 2022
    Type
    Original research
    Journal
    International Health
    Themes/conditions
    Neglected tropical diseases (NTDs general)

    Related publications

    Publication

    Tropical Data: supporting health ministries worldwide to conduct high-quality trachoma surveys

    Publication

    Potential mitigating role of ivermectin on the spread of chlamydia trachomatis by Musca sorbens

    Publication

    Use of digital assessment tools to measure health facility readiness to provide the World Health Organization (WHO) recommended package of care for lymphatic filariasis morbidity

    Sightsavers Logo
    Research centre
    • Join in:
    • Join in: Facebook
    • Join in: X
    • Join in: Instagram
    • Join in: LinkedIn
    • Join in: YouTube

    Protecting sight, fighting disease and promoting equality for all

  • Accessibility
  • Sightsavers homepage
  • Our policies
  • Media centre
  • Contact us
  • Jobs
  • Cookies and privacy Terms and conditions Modern slavery statement Safeguarding

    © 2025 by Sightsavers, Inc., Business Address for all correspondence: One Boston Place, Suite 2600, Boston, MA 02108.

    Our website uses cookies

    To make sure you have a great experience on our site, we’d like your consent to use cookies. These will collect anonymous statistics to personalise your experience.

    Manage preferences

    You have the option to enable non-essential cookies, which will help us enhance your experience and improve our website.

    Essential cookiesAlways on

    These enable our site to work correctly, for example by storing page settings. You can disable these by changing your browser settings, but some parts of our website will not work as expected.

    Analytics cookies

    To improve our website, we’d like to collect anonymous data about how you use the site, such as which pages you read, the device you’re using, and whether your visit includes a donation. This is completely anonymous, and is never used to profile individual visitors.

    Advertising cookies

    To raise awareness about our work, we’d like to show you Sightsavers adverts as you browse the web. By accepting these cookies, our advertising partners may use anonymous information to show you our adverts on other websites you visit. If you do not enable advertising cookies, you will still see adverts on other websites, but they may be less relevant to you. For info, see the Google Ads privacy policy.